Loading news...
GoHealth, Inc. (NASDAQ: GOCO - Get Free Report) shares were down 1.2% during mid-day trading on Monday. The stock traded as low as $2.36 and last traded at $2.37. Approximately 35,917 shares were traded during mid-day trading, a decline of 49% from the average daily volume of 70,720 shares. The stock had previously closed at
Dallas, Texas--(Newsfile Corp. - November 17, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. reported a difficult 3Q25 as the Company continued to navigate a materially different Medicare Advantage environment.
GoHealth, Inc. ( GOCO ) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants John Shave - Vice President of Investor Relations Vijay Kotte - CEO & Director Conference Call Participants Robert McGuire - Granite Research, LLC Patrick McCann - NOBLE Capital Markets, Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division James Sidoti - Sidoti & Company, LLC David Storms - Stonegate Capital Partners, Inc., Research Division Presentation Operator Good day, and welcome to the GoHealth Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
GoHealth (GOCO) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $2.06. This compares to a loss of $3.73 per share a year ago.
CHICAGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its third quarter 2025 financial results on the morning of November 13, 2025.
As millions of Medicare beneficiaries face significant plan disruption for 2026, GoHealth aims to deliver peace of mind As millions of Medicare beneficiaries face significant plan disruption for 2026, GoHealth aims to deliver peace of mind
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2025) - Go Metals Corp. (CSE: GOCO) ("Go Metals" or the "Company") is pleased to announce the start of metallurgical testing at its KM98 Vanadium Titanomagnetite Project in Québec. The program will generate initial data on magnetite and ilmenite concentrates from KM98 mineralization, including the first measurements of concentrate quality.
GoHealth, Inc. (NASDAQ:GOCO ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants John E. Shave - Vice President of Investor Relations Vijay Kumar Kotte - CEO & Director Conference Call Participants David Joseph Storms - Stonegate Capital Partners, Inc., Research Division Ilya Zubkov - Freedom Broker, Research Division James Philip Sidoti - Sidoti & Company, LLC Patrick Joseph McCann - NOBLE Capital Markets, Inc., Research Division Robert Miles McGuire - Granite Research, LLC Operator Good day, and welcome to the GoHealth Second Quarter 2025 Earnings Conference Call.
Dallas, Texas--(Newsfile Corp. - August 8, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a challenged second quarter in 2025, highlighted by revenue declines and contracting margins.
Presentation Operator MessageOperator (Operator)Good day and welcome to the GoHealth Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I
GoHealth (GOCO) came out with a quarterly loss of $1.23 per share versus the Zacks Consensus Estimate of a loss of $2.6. This compares to a loss of $0.75 per share a year ago.
CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025.
NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.
NEW YORK , July 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.
NEW YORK , July 3, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company's existing credit agreement in order to, among other things, provide covenant adjustments as well as extend the maturity of the Company's revolving credit facility through September 30, 2025. The amendment also provides consent for the Company to pursue a receivables financing (such consent also covering a securitization transaction) as the parties continue to work toward a comprehensive financing plan intended to alleviate the Company's recent going concern position, strengthen the Company's financial foundation, provide flexibility and position GoHealth for future sustainable and cash generating growth.
NEW YORK , June 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.